Abstract
Juvenile-onset recurrent respiratory papillomatosis is an exceedingly rare condition. The vast majority of primary care physicians are unlikely to encounter a patient during their entire career. This may explain the typical delay in diagnosis for many children as they are misdiagnosed as having asthma or vocal fold nodules. When diagnosed, these children are usually referred to centers with higher volumes and experience with treating RRP. This has made attempts to monitor the epidemiology of the disease feasible. It is through the study of the epidemiology that clinicians and researchers have gained much knowledge about the clinical aspects of the condition such as incidence, prevalence, clinical course, risk factors for acquisition and disease severity, and response to surgery and novel treatments. This chapter will review the disease burden at a local, national, and global level, the implications of understanding the clinical course of the disease to clinical trials, and the risk factors for acquiring the disease. The chapter will conclude with a glimpse into the future and review ongoing surveillance studies in the era of vaccination programs targeting HPV infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- APSU:
-
Australian Paediatric Surveillance Unit
- CDC:
-
Centers for Disease Control and Prevention
- HLA:
-
Human leukocyte antigen
- HPV:
-
Human papillomavirus
- ICD:
-
International Classification of Diseases
- JoRRP:
-
Juvenile-onset recurrent respiratory papillomatosis
- KIR:
-
Killer-cell immunoglobulin-like receptors
- PPV:
-
Positive predictive value
- RRP:
-
Recurrent respiratory papillomatosis
References
Armstrong LR, Derkay CS. Reeves WC, and the RRP task force. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 1999;125:743–8.
Armstrong LR, Preston EJD, Reichert M, Phillips DL, Nisenbaum R, Todd NW, Jacobs IN, Inglis AF, Manning SC, Reeves WC. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis. 2000;31:107–9.
Baidoo KK, Kitcher ED. Recurrent respiratory papillomatosis: the Korle-Bu experience. Ghana Med J. 2012;46(1):43–5.
Bomholt A. Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region. Acta Otolaryngol (Stockh). 1988;105:367–71.
Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol. 2004;65(8):773–82.
Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, et al. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol. 2010;71(2):212–9.
Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM, McClay JE, Campisi P, Wiatrak BJ, Sobol SE, Schweinfurth JM, Tsuji DH, Hu FZ, Rockette HE, Ehrlich GD, Post JC. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One. 2008;3(5):e2263.
Campisi P, Hawkes M, Simpson K. Canadian juvenile onset recurrent respiratory Papillomatosis working group. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope. 2010;120:1233–45.
Carvalho CM, Huot L, Charlois A, Khalfallah SA, Chapuis F, Froehlich P. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol. 2009;129:462–70.
Derkay CS. Task force on recurrent respiratory papillomatosis. A preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121:1386–91.
Deverell M, Zurynski YA, Elliott EJ. Chief investigators of APSU surveillance studies. Australian Paediatric surveillance unit annual report, 2013. Commun Dis Intell. 2014;38(4):E343–7.
Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR green real-time PCR. Int J Pediatr Otorhinolaryngol. 2006;70(3):469–73.
Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose BR. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol. 1997;35(12):3098–103.
Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, et al. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol. 2003;77(3):1927–39.
Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg. 2005;132(3):392–4.
Gerein V, Soldatski IL, Babkina N, Onufrieva EK, Barysik N, Pfister H. Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation. Int J Pediatr Otorhinolaryngol. 2006;70(12):2061–6.
Gregoire L, Reidy PM, Rabah R, Lancanster WD. HLA-DQ alleles in white and African American patients with juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2003;129(11):1221–4.
Hartley C, Hamilton J, Birzgalis AR, Farrington WT. Recurrent respiratory papillomatosis – the Manchester experience, 1974–1992. J Laryngol Otol. 1994;108:226–9.
Hawkes M, Campisi P, Zafar R, Punthakee X, Dupuis A, Forte V, Lee F-JE. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatr Infect Dis J. 2008;27:149–54.
Leung R, Hawkes M, Campisi P. Severity of juvenile onset recurrent respiratory papillomatosis is not associated with socioeconomic status in a setting of universal health care. Int J Pediatr Otorhinolaryngol. 2007;71(6):965–72.
Lindeberg H, Elbrønd O. Laryngeal Papillomas: the epidemiology in a Danish subpopulation 1965–1984. Clin Otolaryngol. 1990;15:125–31.
Marisco M, Mehta V, Chastek B, Liaw KL, Derkay C. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex Transm Dis. 2014;41(5):300–5.
Mgbor NC, Dahilo EA, Mgbor S. Laryngeal papillomatosis: an 11 year review of 54 cases in Enugu. Nig J Otorhinolaryngology. 2005;2(2):64–6.
Niyibizi J, Rodier C, Wassef M, Trottier H. Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: a systematic review. Int J Pediatr Otorhinolaryngol. 2014;78:186–97.
Novakovic D, Cheng ATL, Baguley K, Walker P, Harrison H, Soma M, Malloy M, Brotherton JML. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. Laryngoscope. 2016;126:2827–32.
Nwaorgu OG, Bakari AA, Onakoya PA, Ayodele KJ. Recurrent respiratory papillomatosis in Ibadan. Niger J Med. 2004;13(3):235–8.
Omland T, Akre H, Vårdal M, Brøndbo K. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122:1595–9.
Omland T, Akre H, Lie KA, Jebsen P, Sandvik L, Brøndbo K. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. PLoS One. 2014;9(11):e113584.
Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol. 2001;4(1):68–72.
Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A. Unger ER, for the RRP task force. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2003;129:976–82.
Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post C, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope. 1997;107(7):915–8.
Seedat RY. The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the free state province of South Africa and Lesotho. Int J Pediatr Otorhinolaryngol. 2014;78:2113–5.
Seedat RY, Thukane M, Jansen AC, Rossouw I, Goedhals D, Burt FJ. HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa. Int J Pediatr Otorhinolaryngol. 2010;74(3):255–9.
Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J. 1998;17(5):372–6.
Shehata BM, Otto KH, Sobol SE, Stockwell CA, Foulks C, Lancaster W, et al. E6 and E7 oncogene expression by human papillomavirus virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP). Pediatr Dev Pathol. 2008;11(2):118–21.
Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg. 2004;130:711–6.
Snowden RT, Thomson J, Horwitz E, Stocks RM. The predictive value of serum interleukins in recurrent respiratory papillomatosis: a preliminary study. Laryngoscope. 2001;111(3):404–8.
Stern Y, Flipovich A, Cotton RT, Segal K. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study. Ann Otol Rhinol Laryngol. 2007;116(3):169–71.
Strong MS, Vaughan CW, Healey GB. Recurrent respiratory papillomatosis. In: Healey GB, editor. Laryngo-Tracheo problems in the pediatric patient. Springfield, IL: Charles C. Thomas; 1979. p. 88–9.
Tasca RA, McCormick M, Clarke RW. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2006;70:1183–7.
Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope. 2004;114(Suppl 104):1–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Campisi, P. (2018). The Epidemiology of Recurrent Respiratory Papillomatosis. In: Campisi, P. (eds) Recurrent Respiratory Papillomatosis. Springer, Cham. https://doi.org/10.1007/978-3-319-63823-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-63823-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63822-5
Online ISBN: 978-3-319-63823-2
eBook Packages: MedicineMedicine (R0)